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remained implanted in 16 patients, explanted in 6, li-
gated in situ in 1, and the outcome was unknown for 1
patient. Among patients with grafts remaining in circu-
lation (16), 2 expired, 3 others required thrombectomy
for graft occlusion, and the other 11 patients had no
reported adverse events. Among the 7 patients with graft
removal/ligation, 3 required an amputation (2 major, 1
minor) and 2 different patients expired secondary to a
pulmonary embolism.
Conclusions: Analysis of the cases with implanted
propaten grafts reveals that theHIT appears to be related to
the systemic administration of heparin, as the platelet count
normalized following discontinuation of the systemic hep-
arin. Hence, based on current data, our recommendation
would be to tailor treatment to individual patients. Func-
tioning grafts in patients with or without thrombotic events
and return of platelet count to normal values may not
require grafts to be explanted.
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Objectives: The objectives of this study were to inves-
tigate the characteristics of decellularized human tissue
engineered vessels (TEV), and to evaluate the in vivo
performance as an arterial graft using a nude rat model.
Methods: Tissue engineered vessels were grown from
human smooth muscle cells that were seeded on a biode-
gradable scaffold using a biomimetic perfusion system. The
fresh and decellularized human TEV were compared using
histology and mechanical analysis. The nude rat model
consisted of implanting the decellularized TEV as an aortic
interpositional graft.
Results: In the decellularized human TEV, the colla-
gen matrix and mechanical strength were preserved in
comparison to fresh TEV. The human TEVs had a high
patency rate without evidence of rupture or aneurysm over
a six week period in a nude rat model. Histological analysis
showed a thin neointima with a confluent endothelium and
a subendothelial layer of smooth muscle cells on the ex-
planted TEV. Transmission electron microscopy on the
explanted tissue confirmed elastin formation in the
neointima.
Conclusions: The human decellularized tissue engi-
neered vessel demonstrated suitable mechanical properties
in vitro, and functioned as an arterial conduit in a small
diameter animal model. The host remodeling suggested
the engineered matrix had a positive effect to create a
regenerated vascular graft.
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Objectives: To evaluate predictors of late mortality
using propensity score matched comparison of open (OR)
or endovascular (ER) revascularization in patients treated
for chronic mesenteric ischemia (CMI).
Methods: The clinical data of 356 patients who had
revascularization for CMI was entered into a database
(1991-2010). Multivariate Cox regression analysis was
used to identify independent predictors of late death (30-
day). A propensity score matched comparison was used to
analyze survival estimates in patients treated with OR or
ER. Clinical risk stratification was reported using standard-
ized SVS score system.
Results: There were 336 patients followed for a me-
dian period of 96 months. Ninety-one patients died during
follow up from cardiac (n30), malignancy (n13), pul-
monary (n9), gastrointestinal (n6), sepsis (n2) or
renal causes (n2). Five patients (1.5%) died from late
complications of CMI; in 29 patients the cause of death was
not determined. Multivariate analysis identified age  80
years, dialysis, and home oxygen therapy as independent
predictors of death. Using a propensity score matched
comparison, survival was nearly identical for patients
Figure. Explant immunohistochemistry of decellularized human
tissue engineered vessel at 6 weeks stained with A) H&E, B)
SmoothMuscle -actin, C) von-Willibrand Factor, D) Elastin Van
Gieson. Scale bar  100 m
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